SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Top 10 Most Recent Blog Posts
Trust in Growth: The Future of Australian REITs
Category: Investing Total Views: 162By : Editor Updated: 05-09-2024
Barnes & Noble Education Inc. (BNED): May 8, 2024 Stock Price Surge
Category: Stocks Total Views: 159By : Editor Updated: 05-09-2024
How the Bank of England's Interest Rate Decision Impacts Your Investments
Category: Economy Total Views: 165By : Editor Updated: 05-09-2024
Stock Market and Economic Outlook for May 9, 2024
Category: Markets Total Views: 154By : Editor Updated: 05-08-2024
5 Best Penny Stocks Under $5: A Snapshot of May 8, 2024
Category: Stocks Total Views: 154By : Editor Updated: 05-08-2024
Today's Stock Market Performance: A Recap of May 8, 2024
Category: Markets Total Views: 202By : Editor Updated: 05-08-2024
Navigating VA Loans in Texas: A Comprehensive Guide for 2024
Category: Personal Finance Total Views: 275By : Editor Updated: 05-08-2024
Small Business Outlook for June 2024: In-Depth Analysis
Category: Business Total Views: 426By : Editor Updated: 05-07-2024
Personal Finance Report: Navigating the Economic Landscape on May 7, 2024
Category: Personal Finance Total Views: 291By : Editor Updated: 05-07-2024
AMBC Stock Analysis: A Deep Dive into Ambac Financial Group Inc.
Category: Stocks Total Views: 405By : Editor Updated: 05-08-2024